Home/Filings/4/0001384101-23-000132
4//SEC Filing

BISHOP JOHN L 4

Accession 0001384101-23-000132

CIK 0001384101other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 8:35 PM ET

Size

13.2 KB

Accession

0001384101-23-000132

Insider Transaction Report

Form 4
Period: 2023-07-17
Transactions
  • Sale

    Common Stock

    2023-07-18$30.50/sh10,000$305,00033,125 total
  • Exercise/Conversion

    Common Stock

    2023-07-17$6.37/sh+10,000$63,70043,125 total
  • Sale

    Common Stock

    2023-07-17$30.00/sh10,000$300,00233,125 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-07-1810,00015,000 total
    Exercise: $6.37Exp: 2024-12-01Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2023-07-18$6.37/sh+10,000$63,70043,125 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-07-1710,00025,000 total
    Exercise: $6.37Exp: 2024-12-01Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023.
  • [F2]Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F3]The option is fully vested.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001189846

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 8:35 PM ET
Size
13.2 KB